ISAK ISAKOV: Open Payments
NPI 1770521775 · FOREST HILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$63,736 in 170 payments from 15 companies in 2025. Trend: 2023 $67,983 · 2024 $70,594 · 2025 $63,736
Speaker / faculty: $39,239Honoraria: $17,551Food & beverage: $4,719Travel & lodging: $1,817Education: $211Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 18 | $19,225 |
| Teva Pharmaceuticals USA, Inc. | 37 | $15,713 |
| Otsuka America Pharmaceutical, Inc. | 14 | $11,674 |
| E.R. Squibb & Sons, L.L.C. | 25 | $8,157 |
| ABBVIE INC. | 17 | $7,359 |
| Alkermes, Inc. | 15 | $436 |
| Neurocrine BioSciences, Inc. | 23 | $331 |
| Vanda Pharmaceuticals Inc. | 7 | $302 |
| Janssen Scientific Affairs, LLC | 1 | $200 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $127 |
Products named: Auvelity, UZEDY, ABILIFY MAINTENA, COBENFY, VRAYLAR, INGREZZA, ARISTADA, FANAPT.
Industry payments across NY — which companies pay providers there.
